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Abstract Superabsorbent polymer (SAP)-containing
wound dressings present a valuable and unique category of
wound management products. An in vitro approach was
used to assess the effects of a new SAP dressing in treat-
ment of non-healing wounds. It was shown that the SAP
dressing possesses a significant binding capacity for
MMP-2 and MMP-9 in vitro (P \ 0.001). The inclusion of
the bound proteases was so strong that no MMP-2 and only
marginal amounts of MMP-9 were released from the
dressing samples in a subsequent elution step. In addition,
the SAP dressing was able to take up collagenase and
reduce its activity in vitro. However, collagenase was not
completely inactivated upon binding and enzyme-mediated
substrate turnover could be observed at the dressings. In
conclusion, in vitro data confirm the positive effect of the
SAP wound dressing observed in vivo. The findings sug-
gest that it should be specifically useful for highly exuding
wounds with an elevated proteolytic activity that needs to






TIMP Tissue inhibitor of matrix metalloproteases
1 Introduction
Non-healing wounds, like venous, pressure and diabetic
ulcer, have become a rising charge to society as an
increasing number of patients suffer from wounds that fail to
heal. Several studies have shown that exudates from these
chronic wounds are characterized by elevated levels of
matrix metalloproteinases (MMPs) [1, 2], contain excessive
amounts of polymorphonuclear granulocyte-derived elas-
tase (PMN elastase) [3–5], and high concentrations of free
radicals [6]. These inflammatory mediators shift the balance
of matrix synthesis and its degradation towards tissue
destruction. The disproportionate action of proteases leads
to considerable reduced amounts of growth factors [7] and
proteinase inhibitors like tissue inhibitors of matrix metal-
loproteases [8]. Hence, modern wound management focuses
on reduction of these inflammatory mediators and creation
of a moist wound environment. Both should aid in estab-
lishing a physiological wound milieu and promote wound
healing. For this purpose, a diversity of occlusive dressings
is available in various forms, such as films, foams, or gels,
made from different materials like alginates, polyurethane,
hyaluronic acid, and collagen. However, highly exuding
wounds may require other options as not all of these mate-
rials are able to handle an excess amount of exudate whose
control is critical in the management of chronic wounds [9].
Therefore, wound dressings containing superabsorbent
polymers (SAP) were devised. SAPs are able to take up a
multiple amount of water of their own dry weight and are
mainly utilized as an absorbent for water and aqueous
solutions in diapers, adult incontinence products, feminine
hygiene products, and similar applications [10]. They are
mainly fabricated from acrylic acid and a crosslinker by
solution or suspension polymerization [10]. The resulting
polyacrylate superabsorbers have a high density of ionic
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charges which accounts for the hydroactive properties
[10, 11] and the protein binding capacity [12–14]. Polyac-
rylate containing wound dressings have been shown to be
particularly effective in the cleansing phase where the pro-
teolytic activity is high and leading to tissue breakdown
[13–15]. A recent study by Eming et al. [13] could show that
polyacrylate superabsorbers can inhibit MMP activity
in vitro and ex vivo. Moreover, it was found that SAP
dressings exhibit a high binding capacity for PMN elastase
and are able to inhibit free radical formation in vitro [12].
The aim of this study was to investigate the binding
properties of a new SAP-containing wound dressing
(Fig. 1) for MMPs. Moreover, the capacity of the SAP
wound dressing to inhibit collagenase activity was ana-
lyzed in vitro.
2 Materials and methods
2.1 Materials
The tested SAP-containing dressing MextraTM Superab-
sorbent was obtained from the manufacturer, Molnlycke
Healthcare Group (UK). Human MMP-2 and MMP-9 were
taken from the specific enzyme immunoassays (ELISA)
from R&D Systems GmbH (Germany). Collagenase was
purchased from Invitrogen (Germany).
2.2 Binding of MMP-2 and MMP-9
Lyophilized MMP-2 and MMP-9 (R&D systems GmbH,
Germany) were reconstituted as recommended in the
manufacturer’s instructions. For further experiments
reconstituted MMP-2 was diluted to a concentration of
5,000 pg/mL while MMP-9 was diluted to a concentration
of 2,000 pg/mL. Wound dressing samples were cut using
8 mm punch biopsies (Stiefel Laboratorium GmbH, Ger-
many) corresponding to 0.5 cm2. The samples were placed
into 24-well cell culture plates (Greiner bio-one, Ger-
many). Glass cover slips (0.5 cm2) were used as controls.
Each specimen was taken in a final volume of 1 mL of
protease solution. Samples were incubated up to 24 h at
37 C on a plate mixer (THERMOstar, BMG Labtech
GmbH, Germany). After incubation, supernatants were
collected, immediately frozen and stored at -20 C until
testing. Subsequently, bound protein was eluted from the
individual wound dressing samples by shaking in 1 mL
PBS for 1 h at 37 C. For determination of the MMP-2 and
the MMP-9 concentrations, the specific ELISAs were
purchased from R&D Systems GmbH (Germany) and run
as recommended by the manufacturer. Optical density was
measured at 450 nm with a reference measurement at
620 nm using a plate photometer (BMG Labtech GmbH,
Germany). Subsequently, the protease concentrations were
evaluated according to a 4-parameter-fit with lin–log
coordinates for optical density (linear scale) and concen-
tration (logarithmic scale).
2.3 Inhibition of collagenase activity
Lyophilized collagenase was reconstituted as recom-
mended in the manufacturer’s instructions (EnzChek Col-
lagenase/Gelatinase assay kit, Invitrogen, Germany). A
1,000 U/mL stock solution of collagenase was prepared in
distilled water. For experiments, the stock solution was
diluted to 0.2 U/mL in the reaction buffer (0.1 M Tris–
HCl, pH 8.0, containing 0.2 mM sodium azide and 0.5 %
bovine serum albumin). Wound dressing samples were cut
using 8 mm punch biopsies (Stiefel Laboratorium GmbH,
Germany) corresponding to 0.5 cm2. The samples were
placed into 24-well cell culture plates (Greiner bio-one,
Germany). Glass cover slips (0.5 cm2) were used as
Fig. 1 The SAP-containing wound dressing consists of a 4-layer
construction (a): wound contact layer, distribution layer, absorbent
core, and a fluid repellent cover sheet (blue). Upon contact with fluid
the absorbent core begins to swell (b). It is comprised of a cellulose
fiber matrix enclosing the SAP particles (c, light microscopic image,
920 magnification)
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controls. Each specimen was taken in a final volume of
1 mL of protease solution. Samples were incubated up to
24 h at 37 C on a plate mixer (THERMOstar, BMG
Labtech GmbH, Germany). After incubation, supernatants
were collected, immediately frozen and stored at -20 C
until testing. Subsequently, bond protein was eluted from
the individual wound dressing samples by shaking in 1 ml
PBS for 1 h at 37 C. Collagenase activity was determined
using the Collagenase/Gelatinase assay kit (Invitrogen,
Germany). The assay was run as recommended in the
instructions. Briefly, 80 lL reaction buffer and 20 lL DQ
gelatin substrate were added, followed by the injection of
100 lL sample. The fluorescence was measured continu-
ously for 1 h at room temperature using a fluorescence
plate reader (FLUOstar Galaxy, BMG Labtech; excitation
wavelength: 495 nm, emission wavelength: 538 nm).
Additionally, eluted dressing samples were incubated for
1 h with 800 lL reaction buffer and 200 lL DQ gelatin.
Afterwards, 200 lL samples were transferred to a black
96-well plate and substrate turnover was measured by
fluorescence intensity (excitation wavelength: 495 nm,
emission wavelength: 538 nm) using a fluorescence plate
reader (FLUOstar Galaxy, BMG Labtech).
2.4 Statistical analysis
All values cited are expressed as means ± SE (standard
error). One-way analysis of variance was carried out to
determine statistical significances (Microsoft Excel
2000). Differences were considered statistically significant
at a level of P \ 0.05. Asterisks indicate significant devi-
ations from the control at the respective incubation time
(*P \ 0.05; **P \ 0.01; ***P \ 0.001).
3 Results
The SAP dressing tested exhibited a significant binding
capacity for MMP-2 in vitro (P \ 0.001; Fig. 2a). The
dressing samples quickly reduced the amount of MMP-2 in
the supernatant upon contact. Moreover, no protein was
detected in the eluate (Fig. 2c). It was observed that the
protease was so tightly bound by the SAP dressing samples
that even disruption of the dressing and aggressive elution
techniques (e.g. vortexing or ultrasonic bath) did not lead
to the release of MMP-2 in vitro. However, bound MMP-2
could be perceived by direct incubation of the disrupted
dressing samples with the respective ELISA antibodies
(Fig. 3a). Moreover, these samples were subjected to light
microscopy, where binding of MMP-2 was verified by the
blue color of the TMB-substrate (Fig. 3b). It could be
shown that MMP-2 is bound to the cortical zone of the
polyacrylate particles. In addition, the SAP dressing was
found to significantly bind MMP-9 in vitro (P \ 0.001;
Fig. 2b). Only a marginal amount of the protease was









































































































Fig. 2 The SAP-containing
wound dressing reduces the
MMP-2 (a) and MMP-9
(b) concentration in a defined
enzyme solution. No MMP-2
was detected in the eluate (c).
Only marginal amounts of
MMP-9 could be eluted from
the samples (d)
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compared to the control (Fig. 2d). Moreover, a significant
effect of the SAP dressing on the activity of collagenase in
the supernatant was observed (P \ 0.001; Fig. 4a). Almost
no enzyme activity was detectable in the eluate (data not
shown). However, it could be demonstrated that the col-
lagenase bound to the dressing samples remains at least
partially active (Fig. 4b). An enzyme-mediated substrate
turnover could be observed directly at the SAP beads of the
dressing (Fig. 5).
4 Discussion
Exudate control is crucial in management of chronic wounds
[9]. The excessive fluid needs to be removed from the wound
(liquid acquisition), quickly dispersed in the dressing (liquid
distribution), and maintained inside the material (liquid
retention). The highest liquid retention can be achieved with
cross-linked, high molecular-weight polyelectrolytes, called
SAPs [11]. Most SAPs are cross-linked networks of flexible
polymer chains with abundant ionizable carboxyl groups,
typically joined with sodium ions [10, 11]. Fluid absorption
occurs through osmotic pressure caused by the concentra-
tion gradient of electrolytes inside and outside the SAP
particles [11]. This process is accompanied by the detach-
ment of the sodium ion, which leaves the charged carboxyl
group behind [10], and the unfolding of the macromolecule
chains, due to the repulsion forces of the negatively charged
sites [11]. This allows the SAP to swell and absorb large
amounts of liquid. During this process, SAPs also take up
and retain proteins, cell debris and even micro-organisms
[12–15]. Binding of proteins is most likely due to electro-
static forces that arise between their positively charged
groups and the negatively charged carboxyl groups of the
polyacrylate. It seems likely that the SAP dressing tested
binds and removes MMPs from the test solution by the same
mechanism, e.g. Eming et al. [13] observed in their experi-
ments a significant reduction of MMP concentration.
Moreover, SAPs have been shown to reduce the concen-
tration of PMN elastase by electrostatic interactions [12].
Likewise, MMPs are known to be bound to other polymers,
such as oxidized regenerated cellulose, collagen or alginate,
Fig. 3 MMP-2 could be
detected in the disrupted
dressing samples by direct
incubation with the respective
ELISA antibodies (a). Light
microscopy of the samples (920
magnification) revealed that
MMP-2 is bound to the cortical
zone of the particles,



















































Fig. 4 Collagenase activity was significantly reduced by the SAP
dressing (a). No collagenase activity was observed in the eluate.
However, collagenase was not inactivated by binding to the SAP;
a significant substrate turnover could be noted when the dressings
were incubated with the collagenase substrate DQ gelatin (b)
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by electrostatic forces [16–18]. In accordance, it was found
that the SAP dressing tested exhibited a significant binding
capacity for MMP-2 and MMP-9 in vitro. Most remarkably
was the fast kinetic of the attachment of the protease to the
SAP, upon contact the enzyme concentration in solution was
decreased. Moreover, binding of MMP-2 was found to be
irreversible and only marginal amounts of MMP-9 could
subsequently be eluted from the material. These results are
similar to the outcome of a recently published study that
demonstrated the binding of MMP-2 as well as MMP-9 and
the inactivation of collagenase by a superabsorbant dressing
[19]. Here, it could further be demonstrated that the prote-
ases are bound to the cortical zone of the SAP particles in the
absorbent layer of the dressing. These findings are in line
with previous reports by Eming et al. [13]. Additional
experiments revealed that incubation with the SAP dressing
reduces collagenase activity by sequestration and removal of
the protease from the fluid in vitro. However, collagenase
activity was not inhibited as the protease remained at least
partially active when bound to the dressing’s core. Compa-
rable results were observed for binding of elastase by other
SAP-containing dressings that were able to take up elastase
and effectively prevent its subsequent release but were not
capable to impede enzyme-mediated substrate turnover [12].
In contrast, Eming et al. [13] observed in their experiments
also an indirect effect of SAP on the MMP activity by
binding of essential Ca2? and Zn2? ions.
5 Conclusion
It can be expected that the SAP dressing achieves a ben-
eficial effect on wound healing not only by absorbing
exudate but also by reducing the concentration of proteases
such as MMP-2 and MMP-9. Hence, it should be particu-
larly effective in the cleansing phase during treatment of
chronic wounds where the proteolytic activity is high and
tissue destruction occurs.
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Fig. 5 Light microscopic images of the SAP dressing show the fibers
and fluid swollen polyacrylate particles of the absorbent layer (a, b).
The fibers exhibit a slight intrinsic fluorescence but the polyacrylate
particle is not visible in fluorescence imaging (ex: 485 nm, em:
520 nm) (c). Polyacrylate particles with bound collagenase became
visible in fluorescence imaging (ex: 485 nm, em: 520 nm) after
incubation with collagenase substrate (d). Hence, it can be concluded
that the SAP beads in the dressing bind the active enzyme and
efficiently remove it from the solution, but collagenase remained at
least partially active. (920 magnification)
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